57.57 USD
+0.36 (+0.63%)
57.58 USD
+0.01 (+0.02%)
Overall MDLZ gets a fundamental rating of 5 out of 10. We evaluated MDLZ against 87 industry peers in the Food Products industry. MDLZ scores excellent on profitability, but there are concerns on its financial health. MDLZ has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
In the past 5 years MDLZ has always been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.95%, MDLZ is in the better half of the industry, outperforming 73.56% of the companies in the same industry.
MDLZ's Return On Equity of 13.49% is amongst the best of the industry. MDLZ outperforms 81.61% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.25%, MDLZ is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 28.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
With an excellent Profit Margin value of 9.38%, MDLZ belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
MDLZ's Profit Margin has declined in the last couple of years.
MDLZ has a Operating Margin of 11.59%. This is in the better half of the industry: MDLZ outperforms 78.16% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
The Gross Margin of MDLZ (31.05%) is better than 72.41% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
2.2 Solvency
MDLZ has an Altman-Z score of 2.28. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MDLZ (2.28) is comparable to the rest of the industry.
The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.31, MDLZ is doing good in the industry, outperforming 64.37% of the companies in the same industry.
MDLZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.76, MDLZ is not doing good in the industry: 63.22% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.28 |
ROIC/WACC0.85
WACC7.38%
2.3 Liquidity
A Current Ratio of 0.61 indicates that MDLZ may have some problems paying its short term obligations.
With a Current ratio value of 0.61, MDLZ is not doing good in the industry: 88.51% of the companies in the same industry are doing better.
MDLZ has a Quick Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ has a Quick ratio of 0.37. This is amonst the worse of the industry: MDLZ underperforms 82.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.70%.
MDLZ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.91% yearly.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 4.13%.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 3.92% on average per year.
The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.20 indicates a rather expensive valuation of MDLZ.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.31. MDLZ is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 17.61, the valuation of MDLZ can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.59. MDLZ is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.2 | ||
| Fwd PE | 17.61 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
MDLZ's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.44 | ||
| EV/EBITDA | 15.99 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.92
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.59%.
Compared to an average industry Dividend Yield of 5.21, MDLZ pays a bit more dividend than its industry peers.
MDLZ's Dividend Yield is a higher than the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.59% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
69.92% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
57.57
+0.36 (+0.63%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners88.19%
Inst Owner Change3.07%
Ins Owners0.14%
Ins Owner Change-0.01%
Market Cap74.29B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts75.88
Price Target70.11 (21.78%)
Short Float %2.09%
Short Ratio3.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.59% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-6.41%
PT rev (3m)-6.63%
EPS NQ rev (1m)-15.25%
EPS NQ rev (3m)-12.77%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.83%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.2 | ||
| Fwd PE | 17.61 | ||
| P/S | 1.97 | ||
| P/FCF | 32.44 | ||
| P/OCF | 20.77 | ||
| P/B | 2.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.99 |
EPS(TTM)2.85
EY4.95%
EPS(NY)3.27
Fwd EY5.68%
FCF(TTM)1.77
FCFY3.08%
OCF(TTM)2.77
OCFY4.81%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.92
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.28 |
F-Score5
WACC7.38%
ROIC/WACC0.85
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.2 and the Price/Book (PB) ratio is 2.84.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.